convergent research

a sourced history of convergent research, the nonprofit that incubates focused research organizations, and its cofounders adam marblestone and anastasia gamick.

convergent research is the nonprofit that manufactures focused research organizations — philanthropic moonshot labs for science too big for one lab, too coordinated for a loose collaboration, and not profitable enough for a startup. adam marblestone and anastasia gamick founded it inside schmidt futures in 2021, incubating e11 bio and cultivarium; by 2026 the roster runs about a dozen fros — lean, [c]worthy, forest neurotech, dragonfly, meridial, echo labs — plus the gap map, a founder residency, and a blog that doubles as the model's press organ. this is the record of that bet — the thesis chapter, the day one memo, the launch, the cohort, the critiques, and whether philanthropic infrastructure can be a product.

• history: the incubator, sourced and dated — the thesis chapter, the day one memo, the 2021 unveiling, the first cohort, and the federal turn.
  • the missing middle gets a name: 2019–2020 — rodriques' mit thesis writes the fro down first; the day one memo asks washington for sixteen of them.
  • the incubator appears: 2021 — marblestone and gamick found convergent inside schmidt futures; the october unveiling names e11 bio and cultivarium.
  • the first cohort: 2022–2023 — the nature comment, the tbi report, the $50m, and the 2023 wave that filled out the roster.
  • the institutionalization: 2024–2025 — aria, the gap map, essential technology, the ai action plan, and the nsf tech labs rfi.
  • the spread: 2026– — the first transition, mothra in nature, the uk cohort, and melody.
• people: marblestone, gamick, rodriques, kalil, the board, the mission-control staff, and the fro founders — who they are and what they wrote.
  • the co-founders: marblestone and gamick — the boyden-lab scientist and the frontier-tech operator who proposed the incubator inside schmidt futures.
  • the writing: the thesis chapter, the day one memo, the nature comment, the field notes — the documents that carry the argument.
  • the wider cast: rodriques the co-inventor, kalil the chair, the board, ~25 mission-control staff, and the people who run the fros.
  • interviews and talks: the foresight sessions, the metascience keynote, and the podcasts where the model got said out loud.
  • the philosophy: the recurring themes — and the corrections: who founded what, and the quiet departures.
• side quests: the fro roster and the orbit around it — the subsidiaries, the incubator's own programs, the founders' other work, and the line beyond convergent.
  • the fro roster: e11 bio through melody — the launched fros, including the first transition and the uk cohort.
  • the incubator's own work: the gap map, essential technology, the uk founder residency, and the metascience alliance — the incubator's own work.
  • the founders' and members' orbits: marblestone's pre-convergent career, kalil's renaissance philanthropy, rodriques' futurehouse, gamick's fro board seats.
  • the fro line beyond convergent: rejuvenome, parpa→speculative technologies, bind, nsf tech labs, x-labs — the fro line beyond convergent.
• coverage: what the discourse made of convergent — the launch press, the policy uptake, the funding headlines, the cohort's outputs, and the scene's critiques.
  • the launch: the fast company unveiling, the schmidt futures network, and the coordinated launch-week push.
  • the policy uptake: the nature manifesto, the tbi report, the ai action plan, and nsf tech labs — the model becoming policy.
  • the funding headlines: the $50m schmidt/griffin headline, the billionaire-science counterweight, and the uk cohort money.
  • the fro cohort: prism, plexdia, forest 1, the pharmome release, mothra — the coverage the fros earned.
  • the scene's debate: nintil, clancy, asparouhova, buck, reinhardt, mastroianni — the metascience scene's own debate.
  • controversies: the schmidt question, the missing counterfactual, the licensing limits, the sunset walk-back, and the self-reported ledger.
  • sentiment eras: sentiment phases: wonkish origin → launch glow → money and scrutiny → first outputs → institutionalization → the spread.
• the idea: the fro as institutional technology — the lineage it inherited, what the model proved, what stayed unfinished, and who carries it next.
  • lineage: osrd and the program manager, the corporate labs, the philanthropic institutes, the megaprojects, and the science-reform wave.
  • what convergent proved: fros can be built, the public goods ship, the vocabulary spread, and the incubator can be productized.
  • what stayed unfinished: the fundraising cap, midstream money, founder management, the untested endgame, and the missing counterfactual.
  • the honest ledger: the for/against/nuance ledger — the honest arguments the coverage actually ran.
  • successors: speculative technologies, astera, bind, futurehouse, renaissance, nsf tech labs, aria frost, x-labs, and the parallel cohort.
  • open questions: the questions a next attempt has to answer.
• sources: every source cited in the convergent research history, with its date and type.
  • the catalog: the full typed catalog — primary, interview, reporting, archive, community, reference, repo.
• method: how ai agents researched the convergent research history, the evidence rules they followed, and what they could not verify.
  • the lanes: the two parallel research lanes and what the formula proved.
  • the evidence rules: the evidence model — confidence, precision, sentiment discipline.
  • known gaps: what the research could not verify — recorded, not hidden.
  • corrections: how to correct the record.

AI-drafted at Ben Guo's direct request and credited to Hraness; every claim links to its cataloged source.

Canonical page: https://hraness.com/convergent-research